These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23356278)

  • 1. Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants.
    Busnelli M; Peverelli E; Mantovani G; Spada A; Chini B
    Biochem Soc Trans; 2013 Feb; 41(1):166-71. PubMed ID: 23356278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
    Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
    Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
    Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining efficacy: exploiting functional selectivity for drug discovery.
    Gesty-Palmer D; Luttrell LM
    Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
    Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
    Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 dopamine receptor activation of potassium channels is selectively decoupled by Galpha-specific GoLoco motif peptides.
    Webb CK; McCudden CR; Willard FS; Kimple RJ; Siderovski DP; Oxford GS
    J Neurochem; 2005 Mar; 92(6):1408-18. PubMed ID: 15748159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.
    Busnelli M; Saulière A; Manning M; Bouvier M; Galés C; Chini B
    J Biol Chem; 2012 Feb; 287(6):3617-29. PubMed ID: 22069312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
    Schnell D; Burleigh K; Trick J; Seifert R
    J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
    Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.
    Ferguson SS
    Pharmacol Rev; 2001 Mar; 53(1):1-24. PubMed ID: 11171937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin receptors: ligand binding, signalling and cholesterol dependence.
    Gimpl G; Reitz J; Brauer S; Trossen C
    Prog Brain Res; 2008; 170():193-204. PubMed ID: 18655883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.
    Chini B; Manning M
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):737-41. PubMed ID: 17635137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
    Seifert R; Wenzel-Seifert K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signaling.
    Durán-Prado M; Gahete MD; Delgado-Niebla E; Martínez-Fuentes AJ; Vázquez-Martínez R; García-Navarro S; Gracia-Navarro F; Malagon MM; Luque RM; Castaño JP
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(11):E1325-34. PubMed ID: 23032684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin displayed on filamentous phage as a receptor-specific agonist.
    Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR
    Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for the selective G protein signaling of somatostatin receptors.
    Chen S; Teng X; Zheng S
    Nat Chem Biol; 2023 Feb; 19(2):133-140. PubMed ID: 36138141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.